Genmab — Februar 2020

[E_L]

Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad? https://www.mdpi.com/2073-4409/9/2/378

[E_L]

pdf
https://sci-hub.tw/https://www.mdpi.com/2073-4409/9/2/378

[E_L]

part of Special Issue "CD38 and Disease: A Bi-Directional Cross-Talk between Pathology and Physiology" https://www.mdpi.com/journal/cells/special_issues/CD38_CD157

[Bulder]

I don't quite get the point here. Do they recommend a dara-break or not?

[E_L]

i think they recomend more research before they can decide that...?

[E_L]

it amazed me before, how much is still unknown about the workings of a drug that sells $3bn a year...

[E_L]

this part has focus on CD38 in Solid Tumors https://www.mdpi.com/2073-4409/9/1/52/htm

[Darvin]

1637 - er det så rødvin igen. Det går altså ikke

[Solsen]

[JKY_VH]

Du har ret Darvin, men på den anden side set så kunne der ske værre ting end at Genmab sætter endnu en kursrekord:-)

[Darvin]

Enig - lad dem bare komme - en efter en, og et par trin tilbage tager vi såmænd
også med

[Sukkeralf]

Tisotumab Vedotin Program Highlights

Tisotumab Vedotin innovaTV 204 Pivotal Trial Data Expected in 2020: Seattle Genetics and Genmab expect to report topline data in the first half of 2020 from the innovaTV 204 pivotal trial of tisotumab vedotin in patients with recurrent and/or metastatic cervical cancer who have relapsed or progressed after standard-of-care treatment.

[Sukkeralf]

Just a moment...

(www.firstwordpharma.com)

[Sukkeralf]

Så ikke rigtig noget nyt derfra !

[Helge_LarsenPI-redaktør]

God morgen.

[bibob]

BCMA- CAR-T. JNJ 4528. https://www.onclive.com/web-exclusives/jnj4528-boasts-high-response-rate-in-relapsedrefractory-myeloma?utm_medium=email&utm_campaign=ONCSS MCL CC eNews NO BANNER 2-6-20 NON-US SEND&utm_content=ONCSS MCL CC eNews NO BANNER 2-6-20 NON-US SEND+CID_b62c0ef5d3c78a81dc8c89fb922e8fc8&utm_source=CM ONCLIVE&utm_term=JNJ-4528 Boasts High Response Rate in RelapsedRefractory Myeloma

[bikube]

Nu får vi da godt nok flyttet ATH deropad.

[Helge_LarsenPI-redaktør]

[E_L]

transcript for SGEN https://seekingalpha.com/article/4322293-seattle-genetics-inc-sgen-ceo-clay-siegall-on-q4-2019-results-earnings-call-transcript?part=single

[E_L]

i think
best to search for TV